Douglas Wurth
About Douglas C. Wurth
Douglas C. Wurth (age 60) is an independent director and Chairman of the Board at Bluejay Diagnostics, Inc. (BJDX), serving in this role since 2017. He brings nearly two decades of senior leadership experience from J.P. Morgan Asset Management and prior legal training, with a B.A. from the University of Notre Dame and a J.D. from the University of Virginia School of Law . The Board has affirmatively determined that Wurth is independent under Nasdaq rules .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| J.P. Morgan Asset Management | CEO of Alternative Investments; CEO of International Private Bank | 1997–2016 | Led global expansion across Asia, Latin America, Europe; senior leadership roles |
| Skadden, Arps, Slate, Meagher & Flom | Attorney | 1992–1995 | Corporate legal practice; foundational legal expertise |
| U.S. Senator Bob Dole’s 1996 Presidential Campaign | General Counsel | 1996 | Oversight of campaign legal matters |
External Roles
| Organization | Role | Public/Private | Tenure/Status | Notes |
|---|---|---|---|---|
| Good Works II Acquisition Corp. | CEO & Director | Public SPAC | Since Feb 2021 | Governance and SPAC leadership |
| Good Works Acquisition Corp. | Co-Chairman | Public SPAC | Since Oct 2020 | Board leadership; interlock with BJDX director Fred Zeidman (Chairman) |
| Standard Power | Chairman of the Board | Private | Current | Private company leadership |
| Vestrata | Chairman of the Board | Private | Current | Private company leadership |
| Triax Technologies | Board Member | Private | Current | Board oversight |
Board Governance
- Roles: Independent Chairman of the Board; Member of Audit, Compensation, and Nominating & Corporate Governance Committees .
- Committee Chairs: None; committee membership only (Chairs: Audit—Gemignani, Compensation—Chase, Nominating—Zeidman in 2024; post-Annual Meeting changes do not alter Wurth’s membership) .
- Independence: Determined independent under Nasdaq rules (Wurth, Chase, Zeidman, Gemignani) .
- Attendance: Board held 11 meetings in 2024; each incumbent director attended at least 75% of Board and applicable committee meetings; all directors attended the 2024 annual meeting .
- Risk oversight: Board separates Chair (Wurth) from CEO (Dey), and committees oversee financial reporting, compensation risk, and governance policies .
Fixed Compensation
| Component | Policy Amount ($) | 2024 Award to Wurth ($) |
|---|---|---|
| Board Chair Retainer | 75,000 | 75,000 |
| Audit Committee Member Fee | 7,500 | 7,500 |
| Compensation Committee Member Fee | 7,500 | 7,500 |
| Nominating & Corporate Governance Member Fee | 7,500 | 7,500 |
| Total Cash Fees | — | 97,500 |
- Director compensation policy is cash-based; no standard meeting fees disclosed beyond committee/member/chair retainers .
Performance Compensation
| Instrument | Grant Date | Shares/Units | Fair Value ($) | Performance Metrics | Vesting |
|---|---|---|---|---|---|
| Stock Awards | — | — | — | — | — |
| Option Awards | — | — | — | — | — |
- No equity awards granted to directors in 2024; no disclosed performance metrics tied to director compensation .
Other Directorships & Interlocks
| Company | Connection Type | Interlock Detail | Potential Impact |
|---|---|---|---|
| Good Works II Acquisition Corp. | External directorship | Wurth is CEO & Director; Zeidman is Chairman | Information flow/network tie; monitor for related-party transactions if any emerge |
| Good Works Acquisition Corp. | External board leadership | Wurth is Co-Chairman; Zeidman is Chairman & CEO | Board-level network overlap with BJDX director; assess future transactions if disclosed |
- No related-party transactions involving Wurth disclosed in BJDX’s proxy; NanoHybrids arrangement relates to CTO Jason Cook (major shareholder of NanoHybrids) and is overseen by the Audit Committee .
Expertise & Qualifications
- Alternative investments and private banking leadership; global expansion experience in Asia, Latin America, Europe .
- Legal training and practice; campaign general counsel experience .
- Board and SPAC leadership; chair roles at private companies; director at industrial technology company .
Equity Ownership
| Holder | Direct Shares | Indirect Shares | Options (Exercisable) | Warrants | Total Beneficial Ownership | % of Class |
|---|---|---|---|---|---|---|
| Douglas C. Wurth | 276 | 138 (Wurth Holdings LLC) | 14 @ $7,624/share | 8 @ $18,360/share | 436 | <1% (based on 1,494,167 SO) |
- Anti-hedging/pledging: Company policy prohibits short sales, hedging, options transactions, and pledging/margin accounts for directors .
- Section 16(a): Insiders complied with filing requirements in 2024 per company review .
Governance Assessment
- Board effectiveness: Independent Chair structure with separate CEO enhances oversight; Wurth serves on all three key committees, indicating broad engagement in audit, pay, and governance .
- Independence and attendance: Board-designated independent; attended at least 75% of Board/committee meetings (aggregate disclosure), and present at annual meeting, supporting engagement .
- Compensation alignment: Director pay is entirely cash-based in 2024 with no equity grants; while simple and non-dilutive, it may reduce long-term ownership alignment for independent directors relative to equity-based structures .
- Ownership “skin in the game”: Wurth’s beneficial ownership is small (<1%); options and warrants are de minimis by share count and at very high exercise prices, limiting near-term alignment via equity .
- Policies and controls: Anti-hedging/pledging policy is shareholder-friendly; Audit Committee pre-approves related-party transactions, and none disclosed for Wurth .
- Network ties: External interlocks with BJDX director Fred Zeidman via Good Works SPACs—no conflicts disclosed, but interlocks can increase perceived information flow; monitor for any transactions between BJDX and these entities .
RED FLAGS
- Low equity-based compensation and small beneficial ownership for an independent Chair may signal limited long-term alignment, particularly in a company undergoing multiple reverse splits and capital needs (contextual risk; no equity awards to directors in 2024) .
- Board interlocks between Wurth and Zeidman at Good Works SPACs warrant continued monitoring for potential related-party exposure if future transactions arise; none disclosed currently .